Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Current Assets: 2009-2024

Historic Current Assets for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to $36.5 million.

  • Cumberland Pharmaceuticals' Current Assets fell 15.03% to $29.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.9 million, marking a year-over-year decrease of 15.03%. This contributed to the annual value of $36.5 million for FY2024, which is 2.07% up from last year.
  • As of FY2024, Cumberland Pharmaceuticals' Current Assets stood at $36.5 million, which was up 2.07% from $35.7 million recorded in FY2023.
  • Over the past 5 years, Cumberland Pharmaceuticals' Current Assets peaked at $50.0 million during FY2020, and registered a low of $35.7 million during FY2023.
  • Over the past 3 years, Cumberland Pharmaceuticals' median Current Assets value was $36.5 million (recorded in 2024), while the average stood at $39.3 million.
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' Current Assets fell by 22.14% in 2023, and later rose by 2.07% in 2024.
  • Cumberland Pharmaceuticals' Current Assets (Yearly) stood at $50.0 million in 2020, then declined by 8.57% to $45.7 million in 2021, then climbed by 0.40% to $45.9 million in 2022, then fell by 22.14% to $35.7 million in 2023, then grew by 2.07% to $36.5 million in 2024.